Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: a real-time PCR study.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Molecular and Cellular Endocrinology

• Publication date

  2006-06-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MCE.2006.03.013PMID 16644101
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: A post mortem in situ hybridization study with special reference to Parkinson's disease

  2005cited by this paper
• Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism.

  2005cited by this paper
• Quantitative analyses of GFRα-1 and GFRα-2 mRNAs and tyrosine hydroxylase protein in the nigrostriatal system reveal bilateral compensatory changes following unilateral 6-OHDA lesions in the rat

  2004cited by this paper
• Biochemical and molecular studies using human autopsy brain tissue

  2003cited by this paper
• Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat.

  2003cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002cited by this paper
• Quantitative assessment of gene expression in highly purified hematopoietic cells using real-time reverse transcriptase polymerase chain reaction.

  2002cited by this paper
• Excitatory amino acids differentially regulate the expression of GDNF, neurturin, and their receptors in the adult rat striatum.

  2002cited by this paper
• Stroke induces widespread changes of gene expression for glial cell line-derived neurotrophic factor family receptors in the adult rat brain.

  2001cited by this paper
• Validation of Endogenous Controls for Gene Expression Studies in Human Adipocytes and Preadipocytes

  2001cited by this paper
• Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain.

  2001cited by this paper
• Glial cell line-derived neurotrophic factor in the substantia nigra from control and parkinsonian brains

  2001cited by this paper
• GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons.

  2001cited by this paper
• Neurotrophic factors in Alzheimer's and Parkinson's disease brain.

  2000cited by this paper
• Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays.

  2000cited by this paper
• Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

  2000cited by this paper
• Differential expression of mRNAs of GDNF family in the striatum following 6‐OHDA‐induced lesion

  2000cited by this paper
• Expression of glial cell line-derived neurotrophic factor and its mRNA in the nigrostriatal pathway following MPTP treatment.

  1999cited by this paper
• Housekeeping genes as internal standards: use and limits.

  1999cited by this paper
• Analysis of the human GDNF gene reveals an inducible promoter, three exons, a triplet repeat within the 3'-UTR and alternative splice products.

  1998cited by this paper
• Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease.

  1998cited by this paper
• Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy

  1997cited by this paper
• GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF.

  1996cited by this paper
• Characterization of a multicomponent receptor for GDNF

  1996cited by this paper
• Functional recovery in parkinsonian monkeys treated with GDNF

  1996cited by this paper
• GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNF

  1996cited by this paper
• Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion.

  1995cited by this paper
• Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons

  1995cited by this paper
• Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult.

  1995cited by this paper
• Multiple astrocyte transcripts encode nigral trophic factors in rat and human.

  1994cited by this paper
• Expression of GDNF mRNA in rat and human nervous tissue.

  1994cited by this paper
• GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

  1993cited by this paper
• Abnormal expression of actin in lymphocytes of Alzheimer's disease and Down's syndrome patients.

  1992cited by this paper
• Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.

  1991cited by this paper

• The role of GDNF in neurodegenerative pathologies

  2026cites this paper
• Inherited Genetic Variation in Parkinson’s Disease: Convergence on Impaired Autophagosome-Lysosome Fusion Through the Altered Expression of mRNA Isoforms

  2025cites this paper
• Exploring the diversity of biological processes regulated by glial cell line-derived neurotrophic factor, a pleiotropic molecule with therapeutic potential

  2025cites this paper
• Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative disease

  2025cites this paper
• The Use of Neurotrophic Factors as a Promising Strategy for the Treatment of Neurodegenerative Diseases (Review)

  2024cites this paper
• Comparative insight into the regenerative mechanisms of the adult brain in zebrafish and mouse: highlighting the importance of the immune system and inflammation in successful regeneration

  2024cites this paper
• Unraveling the role of glial cell line–derived neurotrophic factor in the treatment of Parkinson’s disease

  2023cites this paper
• Advances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases

  2023cites this paper
• Differential expression of RET and GDNF family receptor, GFR-α1, between striatum and substantia nigra following nigrostriatal lesion: A case for diminished GDNF-signaling.

  2023cites this paper
• Differential expression of RET and GDNF family receptor, GFR-α1, between striatum and substantia nigra following nigrostriatal lesion: a case for diminished GDNF-signaling

  2023cites this paper
• Adeno-Associated Viral Vectors as Versatile Tools for Neurological Disorders: Focus on Delivery Routes and Therapeutic Perspectives

  2022cites this paper
• Recent developments in nucleic acid-based therapies for Parkinson’s disease: Current status, clinical potential, and future strategies

  2022cites this paper
• Exploring the Use of Intracranial and Extracranial (Remote) Photobiomodulation Devices in Parkinson’s Disease: A Comparison of Direct and Indirect Systemic Stimulations

  2021cites this paper
• Is activation of GDNF/RET signaling the answer for successful treatment of Parkinson's disease? A discussion of data from the culture dish to the clinic

  2021cites this paper
• Adeno-Associated Virus Vector for Central Nervous System Gene Therapy.

  2021cites this paper
• Mechanistic Insight from Preclinical Models of Parkinson’s Disease Could Help Redirect Clinical Trial Efforts in GDNF Therapy

  2021cites this paper
• Adeno-Associated Viral Vectors as Versatile Tools for Parkinson’s Research, Both for Disease Modeling Purposes and for Therapeutic Uses

  2021cites this paper
• Protection of dopamine neurons by CDNF and neurturin variant N4 against MPP+ in dissociated cultures from rat mesencephalon

  2021cites this paper
• Improving therapeutic potential of GDNF family ligands

  2020cites this paper
• Molecular targets for endogenous glial cell line-derived neurotrophic factor modulation in striatal parvalbumin interneurons

  2020cites this paper
• GDNF/RET signaling in dopamine neurons in vivo

  2020cites this paper
• gdnf affects early diencephalic dopaminergic neuron development through regulation of differentiation‐associated transcription factors in zebrafish

  2020cites this paper
• Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock

  2020cites this paper
• Canine neuropathies: powerful spontaneous models for human hereditary sensory neuropathies

  2019cites this paper
• CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES

  2019cites this paper
• Hyperpolarized 13C magnetic resonance spectroscopy detects toxin‐induced neuroinflammation in mice

  2019cites this paper
• Treatment with the noradrenaline re-uptake inhibitor atomoxetine alone and in combination with the α2-adrenoceptor antagonist idazoxan attenuates loss of dopamine and associated motor deficits in the LPS inflammatory rat model of Parkinson's disease.

  2018cites this paper
• A Parkinson's disease gene, DJ‐1, repairs brain injury through Sox9 stabilization and astrogliosis

  2018cites this paper
• Analyses génétiques et génomiques de maladies neurologiques chez le chien comme modèle de maladies rares humaines

  2018cites this paper
• Biomarkers in Parkinson disease: studies on clinical, radiological and biological biomarkers

  2018cites this paper
• Ischemia‐responsive protein 94 is a key mediator of ischemic neuronal injury‐induced microglial activation

  2017cites this paper
• GDNF and Neurturin isoforms in an experimental model of Parkinson's disease

  2017cites this paper
• Redox‐based therapeutics in neurodegenerative disease

  2017cites this paper
• The Yin and Yang of nucleic acid‐based therapy in the brain

  2017cites this paper
• Complementary proteomic approaches reveal mitochondrial dysfunction, immune and inflammatory dysregulation in a mouse model of Gulf War Illness

  2017cites this paper
• Glial Cell Line-Derived Neurotrophic Factor Gene Delivery in Parkinson's Disease: A Delicate Balance between Neuroprotection, Trophic Effects, and Unwanted Compensatory Mechanisms

  2017cites this paper
• Gx‐50 reduces β‐amyloid‐induced TNF‐α, IL‐1β, NO, and PGE2 expression and inhibits NF‐κB signaling in a mouse model of Alzheimer's disease

  2016cites this paper
• Developing therapeutically more efficient Neurturin variants for treatment of Parkinson's disease.

  2016cites this paper
• A novel translocator protein 18 kDa ligand, ZBD‐2, exerts neuroprotective effects against acute spinal cord injury

  2016cites this paper
• Endogenous recovery after brain damage: molecular mechanisms that balance neuronal life/death fate

  2016cites this paper
• Protection of cultured dopamine neurons from MPP+ requires a combination of neurotrophic factors

  2016cites this paper
• The importance of neuronal growth factors in the ovary.

  2016cites this paper
• Persistent astrocyte activation in the fragile X mouse cerebellum

  2015cites this paper
• RETRACTED ARTICLE: Gene expression profiling analysis of locus coeruleus in idiopathic Parkinson’s disease by bioinformatics

  2015cites this paper
• Small Aβ1–42 oligomer‐induced membrane depolarization of neuronal and microglial cells: Role of N‐methyl‐D‐aspartate receptors

  2015cites this paper
• Compensatory Mechanisms and T Cell Migration In Mouse Models of Dopaminergic Loss

  2015cites this paper
• Does the Cerebrospinal Fluid Reflect Altered Redox State But Not Neurotrophic Support Loss in Parkinson's Disease?

  2015cites this paper
• Increased brain bio-distribution and chemical stability and decreased immunogenicity of an engineered variant of GDNF.

  2015cites this paper
• Altered relation between lipopolysaccharide-induced inflammatory response and excitotoxicity in rat organotypic hippocampal slice cultures during ethanol withdrawal.

  2015cites this paper
• Redox regulation of NF‐κB p50 and M1 polarization in microglia

  2015cites this paper
• Neurotrophic factors GDNF and NRTN : from basic properties to clinical trials

  2014cites this paper
• Inhibition of UDP/P2Y6 purinergic signaling prevents phagocytosis of viable neurons by activated microglia in vitro and in vivo

  2014cites this paper
• Astrocytic metabolic and inflammatory changes as a function of age

  2014cites this paper
• Effects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brain

  2014cites this paper
• 6-Hydroxydopamine induces distinct alterations in GDF5 and GDNF mRNA expression in the rat nigrostriatal system in vivo.

  2014cites this paper
• MS2 phage ribonucleoproteins as exogenous internal control for RT-qPCR data normalization in gene expression study of developing rat brain

  2014cites this paper
• Inflammation induces multinucleation of Microglia via PKC inhibition of cytokinesis, generating highly phagocytic multinucleated giant cells

  2014cites this paper
• Neurotrophic factors GDNF and NRTN : from basic properties to clinical trials

  2014cites this paper
• Traumatic white matter injury and glial activation: From basic science to clinics

  2014cites this paper
• Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis

  2014cites this paper
• Changes in Transcriptional Factor Binding Capacity Resulting from Promoter Region Methylation Induce Aberrantly High GDNF Expression in Human Glioma

  2013cites this paper
• Antibodies bound to Aβ oligomers potentiate the neurotoxicity of Aβ by activating microglia

  2013cites this paper
• Elucidating the role of microglial group III metabotropic glutamate receptors in microglial inflammation : focus on Parkinson's disease and neuroprotection

  2013cites this paper
• Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions

  2013cites this paper
• Age Effects in Substantia Nigra of Asian Indians

  2013cites this paper
• Lactadherin/MFG‐E8 is essential for microglia‐mediated neuronal loss and phagoptosis induced by amyloid β

  2013cites this paper
• Gene expression profiling analysis of the putamen for the investigation of compensatory mechanisms in Parkinson’s disease

  2013cites this paper
• Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro‐inflammatory phenotype

  2013cites this paper
• Retraction Note: Gene expression profiling analysis of the putamen for the investigation of compensatory mechanisms in Parkinson’s disease

  2013cites this paper
• [Levodopa in the treatment of Parkinson disease -- yesterday and today].

  2012cites this paper
• Delivery of neurotherapeutics across the blood brain barrier in stroke.

  2012cites this paper
• S‐nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis

  2012cites this paper
• Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice.

  2012cites this paper
• Lewodopa w leczeniu choroby Parkinsona – wczoraj i dziś

  2012cites this paper
• Endophenotypes as a measure of suicidality

  2012cites this paper
• Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications

  2012cites this paper
• Rhynchophylline Attenuates LPS‐induced Pro‐inflammatory Responses through Down‐regulation of MAPK/NF‐κB Signaling Pathways in Primary Microglia

  2012cites this paper
• On the use of multifactor dimensionality reduction (MDR) and classification and regression tree (CART) to identify haplotype-haplotype interactions in genetic studies.

  2011cites this paper
• Inflammation after trauma: Microglial activation and traumatic brain injury

  2011cites this paper
• Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease

  2011cites this paper
• Parkinson disease: Is GDNF beneficial in Parkinson disease?

  2011cites this paper
• Peripheral nerve pericytes modify the blood–nerve barrier function and tight junctional molecules through the secretion of various soluble factors

  2011cites this paper
• Kaempferol acts through mitogen‐activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells

  2011cites this paper
• Neuroprotective effect of guanosine against glutamate‐induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol‐3 kinase/Akt/ glycogen synthase kinase 3β pathway activation and inducible nitric oxide synthase inhibition

  2011cites this paper
• Expression of N‐methyl D‐aspartate receptor subunits in amoeboid microglia mediates production of nitric oxide via NF‐κB signaling pathway and oligodendrocyte cell death in hypoxic postnatal rats

  2011cites this paper
• NIGROSTRIATAL DOPAMINE-NEURON FUNCTION FROM NEUROTROPHIC-LIKE PEPTIDE TREATMENT AND NEUROTROPHIC FACTOR DEPLETION

  2011cites this paper
• NIGROSTRIATAL DOPAMINE-NEURON FUNCTION FROM NEUROTROPHIC-LIKE PEPTIDE TREATMENT AND NEUROTROPHIC FACTOR DEPLETION

  2011cites this paper
• Identification of Novel GDNF Isoforms and cis-Antisense GDNFOS Gene and Their Regulation in Human Middle Temporal Gyrus of Alzheimer Disease*

  2011cites this paper
• Neurotrophic factors as a protective strategy in Parkinson's disease.

  2010cites this paper
• Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway

  2010cites this paper
• Glial cell line-derived neurotrophic factor (GDNF) and its receptors in human ovaries from fetuses, girls, and women.

  2010cites this paper
• Expression of GDNF receptors GFRalpha1 and RET is preserved in substantia nigra pars compacta of aging Asian Indians.

  2010cites this paper
• Neurotrophic factor therapy for Parkinson's disease.

  2010cites this paper
• Inhibitory effect of fucoidan on nitric oxide production in lipopolysaccharide‐activated primary microglia

  2010cites this paper
• Berberine suppresses neuroinflammatory responses through AMP‐activated protein kinase activation in BV‐2 microglia

  2010cites this paper
• Blueberry supplementation attenuates microglial activation in hippocampal intraocular grafts to aged hosts

  2009cites this paper
• Validation of reference genes for normalization of real‐time quantitative RT‐PCR data in traumatic brain injury

  2009cites this paper
• The NO donor DETA‐NONOate reversibly activates an inward current in neurones and is not mediated by the released nitric oxide

  2009cites this paper
• Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury

  2009cites this paper
• Mechanisms compensating for dopamine loss in early Parkinson disease

  2009cites this paper